Inhibitors of HIV-1 maturation modulate conformational dynamics and heterogeneity of the immature Gag lattice
- 1UMass Chan Medical School
Abstract
HIV-1 maturation requires the viral protease to cleave the Gag polyprotein into its constituent domains. Subsequent conformational and morphological changes result in a mature, infectious virion. Prior studies support a hypothesis in which Gag conformational dynamics and the heterogeneity of the immature Gag lattice enable proteolytic and morphological maturation. We developed a single-molecule Forster resonance energy transfer imaging approach to probe, in real time, the conformational dynamics of individual Gag molecules within immature HIV-1 virions. Our results capture Gag's conformational landscape and the spatial heterogeneity of the immature lattice. We evaluated inhibitors of maturation to identify immature lattice features that are modulated to disrupt maturation. Maturation inhibitors that act through diverse mechanisms, including lenacapavir and compounds that alter viral membrane composition, arrest Gag dynamics and reduce the spatial heterogeneity of the lattice. These observations support a model in which Gag dynamics and immature lattice organization regulate HIV-1 maturation.
Related
- m1A58 acts as a conformational checkpoint coupling human initiator tRNA maturation to translation initiation
- Sex differences in murine bone matrix maturation modulate osteoblast-endothelial interactions.
- Conformational Heterogeneity and Local Electronic Structure in Wild-Type and Arctic Amyloid-Β42
- The intrinsically disordered C-terminal domain of bacteriophage T4 gp32 amplifies pre-existing conformational heterogeneity at DNA replication junctions
- Saponins induce lipid-dependent structural heterogeneity and modulate membrane organization in phospholipid bilayers
BibTeX
@misc{nandi2026inhibitors,
title = {{Inhibitors of HIV-1 maturation modulate conformational dynamics and heterogeneity of the immature Gag lattice}},
author = {T. Nandi and M. Wong and A. A. Waheed and E. O. Freed and C. A. Schiffer and J. B. Munro},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.11.751012},
url = {https://www.biorxiv.org/content/10.64898/2026.09.11.751012v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Inhibitors of HIV-1 maturation modulate conformational dynamics and heterogeneity of the immature Gag lattice
AU - T. Nandi
AU - M. Wong
AU - A. A. Waheed
AU - E. O. Freed
AU - C. A. Schiffer
AU - J. B. Munro
PY - 2026
DA - 2026/09/11
PB - bioRxiv
DO - 10.64898/2026.09.11.751012
UR - https://www.biorxiv.org/content/10.64898/2026.09.11.751012v1
AB - HIV-1 maturation requires the viral protease to cleave the Gag polyprotein into its constituent domains. Subsequent conformational and morphological changes result in a mature, infectious virion. Prior studies support a hypothesis in which Gag conformational dynamics and the heterogeneity of the immature Gag lattice enable proteolytic and morphological maturation. We developed a single-molecule Forster resonance energy transfer imaging approach to probe, in real time, the conformational dynamics of individual Gag molecules within immature HIV-1 virions. Our results capture Gag's conformational landscape and the spatial heterogeneity of the immature lattice. We evaluated inhibitors of maturation to identify immature lattice features that are modulated to disrupt maturation. Maturation inhibitors that act through diverse mechanisms, including lenacapavir and compounds that alter viral membrane composition, arrest Gag dynamics and reduce the spatial heterogeneity of the lattice. These observations support a model in which Gag dynamics and immature lattice organization regulate HIV-1 maturation.
ER -